EU Agency backs new drugs from GSK, Novartis, J&J

[Reuters – UK Focus] – European regulators said on Friday they had recommended approval of 10 drugs, six of which were for respiratory diseases including GlaxoSmithKline’s Anoro and Laventair and Novartis’s Ulunar Breezhaler. … more

View todays social media effects on JNJ

View the latest stocks trending across Twitter. Click to view dashboard

See who Johnson is hiring next, click here to view